Immediate Treatment of Hypoglycemia
For conscious patients with hypoglycemia (blood glucose ≤70 mg/dL), immediately administer 15-20 grams of oral glucose, preferably as glucose tablets or solution, and recheck blood glucose in 15 minutes. 1
Recognition and Threshold for Treatment
- Treat any blood glucose ≤70 mg/dL promptly, even if the patient is asymptomatic 1
- Consider treatment for levels between 60-80 mg/dL depending on clinical context 1
- Early symptoms include sweating, tremor, palpitations, hunger, dizziness, and anxiety (autonomic symptoms) 2, 3
- Neuroglycopenic symptoms include confusion, slurred speech, altered behavior, inability to concentrate, and if untreated, can progress to seizures, unconsciousness, and death 2, 3
Treatment Protocol for Conscious Patients
First-line treatment:
- Give 15-20 grams of glucose orally 1, 4
- Pure glucose (tablets or solution) is strongly preferred because the glycemic response correlates better with glucose content than total carbohydrate content 1, 4
- Glucose tablets and glucose solution are most effective; orange juice and glucose gel are significantly less effective and should be avoided 1, 5
Alternative carbohydrate sources if glucose unavailable:
- Any carbohydrate-containing food with glucose can be used 1, 4
- Sucrose tablets or solution are acceptable alternatives, showing similar efficacy to glucose in research studies 5
- Fruit juice is less effective and not recommended as first-line treatment 1, 5
Follow-up protocol:
- Expect initial response within 10-20 minutes 1, 4
- Recheck blood glucose exactly 15 minutes after carbohydrate ingestion 1, 4
- If hypoglycemia persists at 15 minutes, repeat treatment with another 15-20 grams of carbohydrate 1, 4
- Recheck blood glucose again 60 minutes after initial treatment 1
Special Dosing Considerations
- Patients on automated insulin delivery systems: Consider lower dose of 5-10 grams carbohydrate unless hypoglycemia occurs with exercise or after significant insulin overestimation 1
- Pediatric patients weighing <20 kg (44 lbs): Use 0.3 g/kg of rapid-acting carbohydrate 6
Treatment for Severe Hypoglycemia (Unconscious or Unable to Swallow)
When patient cannot take oral carbohydrates:
- Administer glucagon immediately—newer intranasal and ready-to-inject preparations are preferred over traditional injectable forms due to ease of administration 1, 7
- Adult dose and children ≥25 kg or ≥6 years: 1 mg glucagon subcutaneously or intramuscularly 8
- Pediatric patients <25 kg or <6 years: 0.5 mg glucagon subcutaneously or intramuscularly 8
- If no response within 15 minutes, administer a second dose using a new kit while waiting for emergency services 8
Critical safety measures:
- Turn unconscious patient on their side to prevent choking from vomiting when they awaken 2
- Call emergency services immediately after administering glucagon 2, 8
- Once patient awakens and can swallow, give fast-acting sugar (regular soft drink or fruit juice) followed by long-acting carbohydrate (crackers with cheese or meat sandwich) 2
Important Caveats and Pitfalls
- Do not add fat to carbohydrate treatment—it slows and prolongs the glycemic response 1
- Do not use protein to treat hypoglycemia—it may increase insulin secretion without raising blood glucose 1, 4
- Never delay treatment even for mild hypoglycemia, as it can rapidly progress to severe hypoglycemia 4
- Do not proceed with any medical procedures or evaluations (such as swallow studies) until blood glucose normalizes >70 mg/dL, as hypoglycemia causes altered mental status that can confound assessments 4
- Hypoglycemia symptoms can be mistaken for other conditions; always check blood glucose when in doubt 4
Prevention of Recurrence
- Once treated and stable, have patient consume a meal or snack to prevent recurrence 4, 2
- Ensure at-risk patients always carry glucose tablets or glucose-containing foods 1
- Avoid targeting overly tight glucose control; maintain blood glucose >70 mg/dL 1
- In very young children with recurrent severe hypoglycemia, accept higher glycemic targets to prevent permanent neuropsychological dysfunction 3